Cytomegalovirus in inflammatory bowel disease: A systematic review.

June 5, 2016 at 10:52 am

World J Gastroenterol. 2016 Jan 21;22(3):1321-30. doi: 10.3748/wjg.v22.i3.1321.

Römkens TE1, Bulte GJ1, Nissen LH1, Drenth JP1.

Author information

1Tessa EH Römkens, Loes HC Nissen, Joost PH Drenth, Department of Gastroenterology and Hepatology, Radboud University Nijmegen Medical Centre, 6500 HB Nijmegen, The Netherlands.

Abstract

AIM:

To identify definitions of cytomegalovirus (CMV) infection and intestinal disease, in inflammatory bowel disease (IBD), to determine the prevalence associated with these definitions.

METHODS:

We conducted a systematic review and interrogated PubMed, EMBASE and Cochrane for literature on prevalence and diagnostics of CMV infection and intestinal disease in IBD patients. As medical headings we used “cytomegalovirus” OR “CMV” OR “cytomegalo virus” AND “inflammatory bowel disease” OR “IBD” OR “ulcerative colitis” OR “colitis ulcerosa” OR “Crohn’s disease”. Both MeSH-terms and free searches were performed. We included all types of English-language (clinical) trials concerning diagnostics and prevalence of CMV in IBD.

RESULTS:

The search strategy identified 924 citations, and 52 articles were eligible for inclusion. We identified 21 different definitions for CMV infection, 8 definitions for CMV intestinal disease and 3 definitions for CMV reactivation. Prevalence numbers depend on used definition, studied population and region. The highest prevalence for CMV infection was found when using positive serum PCR as a definition, whereas for CMV intestinal disease this applies to the use of tissue PCR > 10 copies/mg tissue. Most patients with CMV infection and intestinal disease had steroid refractory disease and came from East Asia.

CONCLUSION:

We detected multiple different definitions used for CMV infection and intestinal disease in IBD patients, which has an effect on prevalence numbers and eventually on outcome in different trials.

PDF

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716042/pdf/WJG-22-1321.pdf

Advertisements

Entry filed under: Antivirales no HIV, Biología Molecular, Epidemiología, F.O.D, HIC no SIDA, Infecciones gastrointestinales, Infecciones virales, Metodos diagnosticos, REVIEWS, Sepsis.

Steroid-refractory inflammatory bowel disease is a risk factor for CMV infection. Trough concentration of voriconazole and its relationship with efficacy and safety: a systematic review and meta-analysis


Calendar

June 2016
M T W T F S S
« May   Jul »
 12345
6789101112
13141516171819
20212223242526
27282930  

Most Recent Posts


%d bloggers like this: